|
MRTX1719 Clinical Trials
2 actively recruiting trials across 2 locations
Pipeline
Phase 1: 2
Top Sponsors
- M.D. Anderson Cancer Center1
- Bristol-Myers Squibb1
Indications
- Solid Tumor2
- Cancer2
- Malignant Peripheral Nerve Sheath Tumors1
- Advanced Cancer1
- Mesothelioma1
Phoenix, Arizona1 trial
Phase 1
Houston, Texas1 trial
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
The University of Texas M. D. Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.